Talphera, Inc. ( (TLPH) ) has released its Q3 earnings. Here is a breakdown of the information Talphera, Inc. presented to its investors.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Talphera, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative therapies for medically supervised settings, with a notable emphasis on its lead product candidate, Niyad, which is under investigation as an anticoagulant for extracorporeal circuits.